Shares of Xilinx, Inc. XLNX are up more than 12.5 percent this week following a big Q4 revenue beat. But should traders now be taking profits on Xilinx, or is there more upside in coming months?
Here’s what top firms have to say about the stock now.
Deutsche Bank
Analyst Ross Seymore believes the stock is now fully valued, but “M&A remains a wild card.”
The firm has a Hold rating and $46 target on the stock.
Jefferies
Analyst Mark Lipacis likes the company’s “strong new product growth in most end markets” in Q4.
The firm maintains its Hold rating and upped its price target from $48 to $49.
JMP Securities
Analyst Alex Gauna called the company “a prime acquisition target” and noted its in-line 2016 guidance.
The firm has a Market Outperform rating and $55 target for the stock.
MKM Partners
Analyst Ian Ing said the positive market reaction to earnings was “likely driven more by additional ‘smoke’ as a potential M&A target.”
The firm maintains its Neutral rating and $46 price target.
Nomura
Analyst Romit Shah likes the revenue strength and Nomura “expects the stock to trade higher.”
The firm maintains a Neutral rating and upped its price target from $41 to $43.
Pacific Crest
Analyst John Vinh called the Q4 results “much better than feared.”
The firm has an Overweight rating and $60 target for the stock.
Disclosure: The author has no position in the stocks mentioned.
Image Credit: Public Domain© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.